Study of Remdesivir in Participants Below 18 Years Old With COVID-19
NCT04431453
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Remdesivir
Sponsor
Gilead Sciences